Women with incurable breast cancer in England and Wales will not be offered a life-extending drug on the health service after talks between the NHS spending watchdog and its manufacturer ended without an agreement on price for the third time.
Women with incurable breast cancer in England and Wales will not be offered a life-extending drug on the health service after talks between the NHS spending watchdog and its manufacturer ended without an agreement on price for the third time.